Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 4/20 | 0.43 |
| ▸ | NOS1 | P29475 | 4/20 | 0.43 |
| ▸ | NOS2 | P35228 | 4/20 | 0.43 |
| ▸ | INMT | O95050 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6860421 | 0.91 | NOS3 (0.48) | NOS3NOS1NOS2INMTUSP2 | |
| SCHEMBL6859100 | 0.89 | NOS3 (0.47) | NOS3NOS1NOS2INMTUSP2 | |
| SCHEMBL20686772 | 0.88 | NOS3 (0.45) | NOS3NOS1NOS2INMTUSP2 | |
| SCHEMBL809703 | 0.77 | INMT (0.36) | INMTUSP2 | |
| SCHEMBL20686763 | 0.72 | USP2 (0.33) | NOS3NOS1NOS2INMTUSP2 | |
| SCHEMBL809360 | 0.72 | INMT (0.37) | NOS3NOS1NOS2INMTUSP2 | |
| SCHEMBL21985369 | 0.71 | INMT (0.34) | INMTUSP2 | |
| SCHEMBL20686776 | 0.71 | INMT (0.36) | NOS3NOS1NOS2INMTUSP2 | |
| SCHEMBL15437769 | 0.71 | NOS1 (0.53) | NOS3NOS1NOS2INMTUSP2 | |
| SCHEMBL810067 | 0.71 | INMT (0.39) | INMTUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11384172-B2 | Polymer, antimicrobial agent, disinfectant, antimicrobial material, disinfectant material, antimicrobial method, and disinfecting method | JSR CORPORATION (JP) | 2022-07-12 | — | — | US | disclosed |
| US-20190284436-A1 | COMPOSITION AND METHOD FOR TREATING SEMICONDUCTOR SURFACE | JSR CORPORATION (JP) | 2019-09-19 | — | — | US | disclosed |
| US-6794530-B1 | 1,4-ADDITION OF MONOHYDRIC OR POLYHYDRIC ALCOHOLS TO ALPHA , BETA -UNSATURATED NITRILES | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-21 | — | — | US | disclosed |
| US-6130347-A | REACTING MONOCHLOROACETIC ESTER WITH HYDROGEN CYANIDE IN BASE PRESENCE; CYANATION | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11384172-B2 | Polymer, antimicrobial agent, disinfectant, antimicrobial material, disinfectant material, antimicrobial method, and disinfecting method | H1-5, DRD5, NRDC | NOS3 444/4885NOS1 171/4885NOS2 431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.